This is the question most patients do not think to ask, and it is where the real nuance lives
If you've been researching medical weight loss, you've almost certainly come across two names: semaglutide and tirzepatide
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and chronic weight management
for this reason, physicians typically advise patients to dose in a fasted state, whether at bedtime or earlier in the day
Improved skin elasticity and thickness
In ATTAIN-1, the familiar cluster appeared again: nausea, diarrhoea, constipation, vomiting, indigestion, and abdominal pain, mostly mild to moderate and concentrated during the weeks when the dose was being stepped up